 |
levitra dangers
Levitra Dangers from Google Approved Pharmacy
|
| Welcome |
|
|
Welcome to buylevitra.
You are currently viewing our boards as a guest, which gives you limited access to view most discussions and access our other features. By joining our free community, you will have access to post topics, communicate privately with other members (PM), respond to polls, upload content, and access many other special features. Registration is fast, simple, and absolutely free, so please, join our community today! |
| Forum |
Topics |
Posts |
Last Post |
| Test category 1 |
|
 |
|
levitra dangers
Levitra
Levitra (Vardenafil) is an oral therapy for the treatment of erectile dysfunction. Having the long-lasting effect of 25 hours, and the start time of 25 min, Levitra represents an uncontested advantage in comparison to Viagra.
Concomitant Medications
The dosage of LEVITRA may require adjustment in patients receiving potent CYP3A4 inhibitors such as ketoconazole, itraconazole, ritonavir, indinavir, saquinavir, atazanavir, and clarithromycin as well as in other patients receiving moderate CYP3A4 inhibitors such as erythromycin (see WARNINGS, PRECAUTIONS, DRUG INTERACTIONS). For ritonavir, a single dose of 2.5 mg LEVITRA should not be exceeded in a 72-hour period. For indinavir, saquinavir, atazanavir, ketoconazole 400 mg daily, itraconazole 400 mg daily, and clarithromycin, a single dose of 2.5 mg LEVITRA should not be exceeded in a 24-hour period. For ketoconazole 200 mg daily, itraconazole 200 mg daily, and erythromycin, a single dose of 5 mg LEVITRA should not be exceeded in a 24-hour period. For alpha-blockers, caution is advised when PDE5 inhibitors, including LEVITRA, are used concomitantly with alpha-blockers because of the potential for an additive effect on blood pressure. In some patients, concomitant use of these two drug classes can lower blood pressure significantly (see PRECAUTIONS, Alpha-blockers and DRUG INTERACTIONS) leading to symptomatic hypotension (e.g., fainting). Concomitant treatment should be initiated only if the patient is stable on his alpha blocker therapy. In those patients who are stable on alpha-blocker therapy, LEVITRA should be initiated at a dose of 5 mg (2.5 mg when used concomitantly with certain CYP3A4 inhibitors - see DRUG INTERACTIONS).
|
|
1 |
1 |
Thu Apr 10, 2008 2:05 pm
buylevitra  |
| Who is Online |
 |
Our users have posted a total of 1 article
We have 1 registered user
The newest registered user is buylevitra
|
In total there is 1 user online :: 0 Registered, 0 Hidden and 1 Guest
[ Administrator ] [ Moderator ]
Most users ever online was 5 on Mon Sep 08, 2008 11:01 am
Registered Users: None
|
| This data is based on users active over the past five minutes |
 |
New posts |
|
|
No new posts |
|
 |
Forum is locked |
Community Chest
|
FAQ
Search
Memberlist
Usergroups
Register
Profile
Log in to check your private messages
Log in